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Abstract mRNA stability is a limiting parameter for the 
efficiency of in vitro protein biosynthesis. In order to develop 
strategies to prolong the mRNA half-life, we investigated the 
ribonuclease activities in the complete Escherichia coli system, in 
the separate cell fractions 70S ribosomes and S-100 and in the 
non-cellular fraction. Our results imply that the amount of 
ribonucleolytic activities and the insensitivity to placental RNase 
inhibitor in the complete system are due to the 70S ribosome 
fraction, whereas the generation of small degradation products is 
due to the S-100 fraction. Remarkably, the human placental 
RNase inhibitor is able to reduce mRNA degradation in the 
bacterial S-100 fraction. 
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I. Introduction 
Cell-free protein synthesis is a useful tool for the production 
of cytotoxic, regulatory or unstable proteins which cannot be 
(over)expressed in living cells [1]. Further advantages of in 
vitro translation are the synthesis of only one desired product, 
the possibility of facilitated and accelerated product isolation 
procedures by the use of peptide tags [2,3] and the capability 
of directed incorporation of modified amino acids [4,5]. Var- 
ious in vitro translation systems were established based on
components of prokaryotic or eukaryotic organisms and per- 
sistent efforts were made to increase their protein yields. 
Our Escherichia coli in vitro translation system [6] consists 
of amino acids, energy providing factors, buffer, salts, several 
additional reactants, E. coli tRNAs, E. coli initiations factors, 
mRNA and E. coli 70S ribosomes and S-100. In such a reac- 
tion mixture the mRNA is degraded by ribonuclease activities 
associated with the cell fractions. Since mRNA stability is one 
of the major parameters limiting the efficiency of in vitro 
protein synthesis, it is very important that an improved in 
vitro translation system with increased mRNA half-life is de- 
veloped. 
In this study we investigate the degradation of the mRNA 
encoding the ribosomal protein L18 of E. coli during in vitro 
translation and the influence of the human placental RNase 
inhibitor. Based upon the results obtained new strategies are 
discussed for prolonging the half-life of mRNA.  
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2. Materials and methods 
2.1. In vitro transcription 
The radiolabelled mRNA transcript was obtained by in vitro tran- 
scription of the HindlII-linearized plasmid pKK504-3 carrying the 
gene for the protein L18 with T3 RNA polymerase following the 
protocol of Triana-Alonso et al. [7] with some modifications. The 
reaction mixture, which was incubated for 120 min at 37°C, contained 
40 mM Tris-HC1 (pH 8.1), 22 mM MgC12, 20 nM plasmid DNA, 
5 mM DTE, 0.1 I.tg/pl BSA, 1 mM spermidine, 1 U/l.tl human pla- 
cental RNase inhibitor (Boehringer Mannheim), 2 U//.tl T3 RNA po- 
lymerase (Boehringer Mannheim), 3.75 mM ATP, GTP and UTP, 
whereas the concentration of CTP was 2.5 mM only, and [ot-32p]CTP 
(Amersham) with a specific activity of 3.3 /.tCi/pmol was added to 5 
~tCi/~l. Then the transcription mixture was treated with 1 U/lal DNase 
I (Boehringer Mannheim) for 20 rain at 37°C, incubated for 4 rain at 
55°C and cooled down to 35°C within 120 min. Afterwards the rena- 
tured mRNA transcript was isolated by phenol, chloroform and dieth- 
ylether extraction and purified by gel filtration with fractionating elu- 
tion using a NICK column (Pharmacia). The peak fractions were 
pooled and the RNA concentration was determined at 260 nm. The 
integrity of the mRNA was analyzed by denaturing electrophoresis on 
a 6% polyacrylamide/7 M urea gel [8]. 
2.2. In vitro translation 
The cell-free protein synthesis reaction was performed according to 
Baranov and Spirin [9] applying 150 nM radiolabelled pKK504-3/ 
HindIII transcript as mRNA template. Human placental RNase in- 
hibitor was added to a final concentration of 0.1 U/~tl. 
The preparation of 70S ribosomes and S-100 from E. coli D10 
(relA1, spoT1, metB1, RNase F )  [10] was carried out as described 
by Gold and Schweiger [11] except hat the ribosomes were ultracen- 
trifuged in the presence of 500 mM ammonium chloride. 
2.3. mRNA decay assays 
150 nM purified and radiolabelled mRNA was incubated in the 
entire ih vitro translation mixture or in incomplete mixtures lacking 
either 70S ribosomes or S-100 or both. For electrophoretic analysis 
aliquots of 15 ~tl were removed after 0, 10, 20, 30, 40, 50, 60 min of 
incubation, diluted with 45 ~tl ice-cold DEPC-treated water, extracted 
successively with 60/al phenol and 60/.tl chloroform and deproteinized 
by treating the samples with 500 ng/~tl proteinase K (BRL) for 3 min 
at 60°C. Their Cerenkov radiation was determined and the mRNA 
and its degradation products were analyzed by denaturing electropho- 
resis as described in Section 2.1. After autoradiography the bands of 
intact mRNA were cut out of the gel and their Cerenkov radiation 
was measured. For TCA precipitation two samples, 10 ~tl each, were 
taken out of the reaction mixture at the same time points as for the 
Table 1 
Full-length mRNA half-life (min) 
Complete system+Rl 4.9 
Complete system-RI 4.7 
70S ribosomes+RI 10.7 
70S ribosomes-Rl 10.0 
S-100+RI 41.3 
S-100--RI 18.1 
Comparison of effects of cell fractions and RNase inhibitor (RI) on 
full-length L18 mRNA half-life calculated from Fig. I. More details 
are given in the text. 
All rights reserved. 
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Fig. 1. Comparison of effects of the cell fractions on degradation of full-length mRNA analyzed electrophoretically by measuring the radioac- 
tivity of the bands of intact mRNA. Time course of mRNA decay (A) in the complete in vitro translation system, (B) in the partial system 
with the non-cellular components and70S ribosomes and (C) in the partial system with t e non-cellular components and S-100, each with 11~) 
or without (~) RNase inhibitor. 
etectrophoresis. The mRNA and its degradation products longer than 
about 50 nt were precipitated with 5% TCA [12] and quantified by 
Cerenkov counting. 
3. Results 
The mRNA transcript used in our experiments has an over- 
all length of 407 nt consisting of the 29 nt long non-coding 5'- 
terminal region, including the translation initiation signals, 
and the sequence ncoding protein L18. The molecule lacks 
an untranslated Y-terminal segment and the immediate 3'-end 
is constituted by the stop codon. 
The full-length mRNA decay kinetics in the complete E. 
coil in vitro translation system (Fig. I A) shows a considerable 
mRNA degradation process with an insignificant protective 
efficacy of RNase inhibitor, similar to the course of mRNA 
decay in the partial system with 70S ribosomes (Fig. IB). 
Nevertheless, in the case of 70S ribosomes, the degradation 
is somewhat less and the effect of RNase inhibitor is slightly 
increased. Contrarily, the partial system with S-100 shows a 
quite different course of mRNA decay (Fig. 1C, Table 1) with 
an extended mRNA half-life and a significant protection by 
RNase inhibitor. Compared with the partial systems with the 
separate cell fractions (Fig. 2B,C), the complete in vitro trans- 
lation system (Fig. 2A) yields a large quantity of small mRNA 
degradation products. Corresponding to the full-length 
mRNA decay kinetics only the partial system with S-100 
shows a significant influence of RNase inhibitor on the 
amount of the TCA-precipitable mRNA portion. 
Summarizing the results leads to a scheme of mRNA prod- 
ucts (Fig. 3), reflecting the effects of the cellular and non- 
cellular components on mRNA turnover (Fig. 4). The main 
ribonuclease activities occur in the cell fractions. The non- 
cellular components contain very little RNase activity, which 
is almost totally inhibitable by the RNase inhibitor. The re- 
sults suggest hat quantity and insensitivity to RNase inhib- 
itor of the mRNA degradation process in the complete in 
vitro translation system are dominated by the 70S ribosome 
fraction while the capacity to generate small degradation 
products is predominantly provided by the S-100 fraction. 
4. Discussion 
The mRNA degradation process in the complete in vitro 
translation system is due to the interaction of both cell frac- 
tions combining the intensive, hardly inhibitable ribonuclease 
activity of 70S ribosomes with the highly processive capacity 
of S-100. Obviously, this co-operation is in accordance with 
the general model for the mechanism of mRNA degradation 
in prokaryotes describing a concerted action of endonucleases 
and processive 3'-~ 5'-exonucleases [13,14]. Our  results agree 
with previous findings showing that the prevalent 3' ~ 5'-exo- 
nucleases involved in mRNA degradation i E. cell, RNase II 
and PNPase [15], are mainly found in the soluble cell fraction 
[16,17]. Such exoribonucleolytic a tivities gi~e rise to the loss 
of coding sequence including the stop codon, entailing incom- 
plete, possibly functionally truncated proteins and in vivo 
selective proteolysis [18]. Hence, the most important step to 
prolong mRNA half-life is the impairment of the 3'--* 5'-exo- 
nucleases, for example by Y-terminal, protective structural 
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Fig. 2. Comparison of effects of the cell fractions on formation of small mRNA degradation products ( < 50 nt) analyzed by measuring the ra- 
dioactivity of the TCA-precipitable mRNA portion (full-length mRNA and fragments > 50 nt). For graph designation see Fig. 1. 
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Fig. 3. Comparison of effects of the separate components on quality 
and quantity of mRNA degradation products ummarizing the elec- 
trophoretic analysis and the TCA precipitation assays. Portions of 
intact mRNA (full-length mRNA band, white bars), long mRNA 
degradation products (TCA-precipitable portion minus intact 
mRNA, fragments > 50 nt, black bars) and small mRNA degrada- 
tion products (TCA-soluble portion, fragments < 50 nt, gray bars) 
after 60 rain of incubation in the complete in vitro translation sys- 
tem with (a) or without (b) RNase inhibitor, in the partial system 
with the non-cellular components and 70S ribosomes with (c) or 
without (d) RNase inhibitor, in the partial system with the non-cel- 
lular components and S-100 with (e) or without (f) RNase inhibitor, 
in the non-cellular components with (g) or without (h) RNase inhib- 
itor and as the control in DEPC-treated water with (i) or without 
(j) RNase inhibitor. 
barriers like REP sequences and intrinsic terminators ([19], 
our laboratory, unpublished results). Since E. coli strains de- 
ficient in RNase II, PNPase, RNase E, RNase III or RNase I 
are available, further potential to diminish the amount of 
ribonucleolysis is given by the use of appropriate bacterial 
strains for isolation of cell fractions and the modification of 
their preparation procedures. 
The poor protective fficacy of RNase inhibitor in the com- 
plete in vitro translation system is consistent with its insignif- 
icant effect on protein yields (unpublished results). On the 
h g d c f e b a j i k 
other hand, the human RNase inhibitor is able to reduce 
the ribonuclease activities in the non-cellular components 
and in the S-100 fraction of E. coli. 
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Fig. 4. Autoradiogram of the mRNA (lane k, arrow) and its degra- 
dation products after 60 rain of incubation. For lane designation 
see Fig. 3. 
